Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease:

Dementia Big
Dementia and other tauopathies, most notably Alzheimer’s disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in the human brain. These diseases represent one of the leading causes of death and disability in the elderly population in the western world, with no current effective therapy.

http://ift.tt/1UpRTcR